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ABSTRACT
Liver cirrhosis is a chronic and irreversible disease. The patients quality of life (QOL) may be impaired
because of long-standing burden of the disease. This research was a cross-sectional study conducted at Dr.
Sardjito Hospital, Yogyakarta to determined the QOL of patients with liver cirrhosis who hospitalized in this
institution. The parameter for the QOL was measured according to Spitzer index. Sixty-five patients with
liver cirrhosis of various etiology were abled to be studied. The number of male and female patients were
almost equal (30 and 35 respectively). There was a reduction in QOL in both male (21/30) and female (28/
35) but no significant different between this variable. There was a significant positive correlation between
Child criteria, and nutritional status with QOL (r=0.68, p<0.05 and r=0.37, p<0.05). It was concluded that
Child criteria and nutritional status were positively correlated with QOL.
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INTRODUCTION
Cirrhosis is a chronic and irreversible liver disease,
anatomically marked by presence of diffused liver
fibrosis with regeneration nodules resulting from
hepatocellular necrosis caused by various etiologies.
Complications that occur are due to portal hypertension
and deterioration of liver function.1
According to Adenan et al (1990), the most
commonly found complaints among in-patients with liver
cirrhosis at Dr Sardjito Hospital were ascites,
hematemesis, and/or melena, encephalopaty, fatigue, and
yellow eyes.
Cirrhosis is a late or terminal chronic liver disease.
Like other chronic diseases, the medical and non-
medical means of therapy are aimed to overcome
complications, and thereby directly decreasing patient
mortality rate.3
Younossi & Guyatt (1998) mentioned the patient’s
quality of life as a part of the outcome of therapy.
Therefore, it is mandatory to evaluate the patient’s
quality of life in routine management of the patient. The
results of further evaluation can be taken into
consideration in making decisions for further
management of the treatment.3
Lately, numerous studies about the quality of life of
patients suffering from chronic diseases have been
conducted, beside the routine biomedical assessment.
Some researches on quality of life that have been
conducted are that in patients with chronic renal
disease,5 post myocardial infarction, and cancer.6
Research on the quality of life in the field of
gastro-hepatology has been conducted on post-hepatic
transplantation patients,7 evaluation on interferon therapy
on the patients with chronic hepatitis C,8 comparison of
the quality of life of patients with chronic hepatitis C
with normal population and the patients with
Inflammatory Bowel Disease (IBD).9
Even though there has not been any specific research
on the quality of life of patients with liver cirrhosis, the
presence of ascites is thought to lower their quality of
life. Thus, adequate management of ascites, either with
drugs or by means of surgery, should be able to improve
their quality of life.10
This research was conducted to determine the
quality of life of patients with liver cirrhosis and to
determine the factors influencing the quality of life of
patients, such as clinical criteria (Child), nutritional sta-
tus, sex, and age.
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By knowing the quality of life of patients with liver
cirrhosis and the influencing factors, we could determined
the priority for secondary prevention against the
morbidity factors that increase the quality of life of
patients, or on the other way around.
MATERIAL AND METHOD
This study was conducted cross-sectionally on the
patients of liver cirrhosis hospitalized at Dr Sardjito
Hospital, Yogyakarta.  The study took place at the
Internal Medicine Unit of Dr. Sardjito Hospital,
Yogyakarta, from January 1999 to October 1999.
The research subjects consisted of patients with liver
cirrhosis diagnosed based on clinical features, laboratory
findings, and ultrasound examination, hospitalized at Dr.
Sardjito Hospital. Patients included in the research were
patients with various etiologies of liver cirrhosis, such as
viral hepatitis, alcohol, hematochromatosis, and billiary
cirrhosis.  Patients were included in the research if they
were stable, without acute hematemesis, encephalopathy,
sepsis, or tense ascites disturbing respiratory tract.
Patients with chronic diseases such as cardiac
decompensation, chronic renal failure, obstructive lung
disease, diabetes mellitus, or those suffering from an acute
episode of a disease were excluded from the study.
Prior to the commencement of the study, the patients
were briefed on the purpose of the study, the methods,
and usage.  If the patient had no objections, then the
study would be initiated in that patient. Medical history
was taken while the patients were hospitalized, when
they visited the polyclinic as an out-patient, and during
home visits.  Medical variables, such as the primary
diagnosis, nutritional status and other conditions, were
obtained from patient’s medical record.
Determination of the patient’s nutritional status was
based on the circumference muscle of the upper arm
(CUAM), circumference of upper arm (CUA), and the
thickness of the fat of triceps muscle (TFTM), using the
Bishop formula:
• CUAM = CUA – (0.314 x TFTM)
• CUAM > 85% of standard is considered to demon-
strate adequate nutrition
• CUAM 71-85% of standard is considered to dem-
onstrate mild malnutrition
• CUAM < 70% of standard is considered to demon-
strate severe malnutrition
The parameter for the quality of life was based on
an Indonesian translation of validated quality of life’s  index
from Spitzer. The grade of liver cirrhosis was clinically
determined based on Child-Pugh criteria.
Based on the study on the quality of life of patients
with chronic liver disease undergoing liver
transplantation, about 30-70% of patients have a reduced
quality of life. Thus the sample size can be calculated
using the following formula:
   Z2 1 - a/2 p (1 – p)
n =
   d2
p:  proportion in population; d:  precision
(1.960)2  x 0.3 (1-0.3)
(0.1)2 = 80 subjects of research
If the precision used is 0.10 with a co-efficient of
reliability of CI=95%, and Z=1.960, then the number of
samples is as follows:
Table 1.  Distribution of Patients Based on Age to Sex 
Age Male Female 
<20 0 1 
20-29 1 1 
30-39 3 1 
40-49 5 4 
50-59  6 13 
>70 3 4 
Sum  30 35 
X2=4.52; p>0.05 
In this study, we found no statistical difference on
the Child criteria between male and female patients
(Table 2).
From the collected data, we calculated the mean to
be further analyzed using correlation analysis and
chi-square to determine proportional data with a level of
significance p<0.05.
RESULTS
In 10 months (January-October 1999), there were
65 qualified patients with liver cirrhosis, consisting of 30
men and 35 women. Distribution based on age and sex
demonstrated that liver cirrhosis was found mostly in
the group of people ages 60-69 years old (23 patients).
The number of male patients with liver cirrhosis was
almost the same as the number of female patients, with
a ratio of 3:3.5 (Table 1).
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Other than the data mentioned above, this study also 
found a positive correlation between the Child criteria 
and the quality of life (r=0.6819; p<0.05), as well as 
between the patient’s nutritional status and quality of life 
(r=0.3715; p<0.05).   On the other hand, there was no 
correlation between sex or age and the quality of life, 
There was no statistical difference on the nutritional 
status between male and female patients (Table 3). 
 
 
 
 
 
 
 
In this study, there was a reduction in the quality of 
life of patients with liver cirrhosis. However, there was 
no statistically significant difference between men and 
women (Table 4). 
 
 
 
 
 
 
 
In previous studies it was found that the Child 
criteria has an influence on the patients’ quality of life. 
The same findings were obtained in this study, demon- 
strating a statistically significant relationship between 
Child criteria and the quality of life (Table 5). 
 
 
 
 
 
 
 
 
This study determined that the nutritional status 
affects the quality of life, demonstrating a statistically 
significant relationship when analyzed (Table 6). 
resulting in an r of r=0.0490, p>0.05 and r=0.1107, p>0.05, 
respectively. 
DISCUSSION 
If untreated, the disease rapidly accelerates health  
state, loss of function, and discomfort. On the other hand,  
therapy itself could cause unpleasant side effects.  
Thereby, to understand these effects completely, treat- 
ment should take into consideration the patient’s quality  
of life.  Precise evaluation of the patient’s quality of life  
would be useful to determine the disease process and  
the effect of the therapy given to the patients.  The  quality  
of life of patients with liver cirrhosis undergoing therapy  
should be assessed. Without treatment, patient with liver  
cirrhosis will die, be it caused by the disease itself or by  
its complications.11 
In generally, the quality of life of patients with liver  
cirrhosis is reduced. This has been proved by various  
researchers.  Vogel et al (1995) studied 620 patients with  
liver cirrhosis. The patients were followed for over 15  
years and then compared to the normal population. It  
concluded that the quality of life of patients with liver  
cirrhosis was significantly different, in which the quality  
of life of patients with liver cirrhosis was generally worse.  
 In this study, none of the study subjects scored 10 on  
the quality of life.  It could be inferred that liver cirrhosis  
patients treated in Dr Sardjito Hospital from January till  
October 1999 had a lower than normal quality of life.  
Specifically, there were 16 patients with scores 8-9  
(24.6%), 35 with scores 5-7 (53.8%), and 14 with scores  
<5 (21.5%). 
This study also proved that there were variables or  
factors positively correlated to the quality of life of  
patients with liver cirrhosis.  These factors were Child  
criteria and the nutritional status of the patient, while  
age and sex had no correlation with the patient’s quality  
of life. 
A.1. Sex 
Sixty-five people, consisting of 30 (46.2%) men and  
35 (53.8%) women included in the study. Based on the  
analysis, sex did not influence the patient’s quality of life  
(r=0.0490; p>0.05). From his study, Nose et al. (1995)  
concluded that males had a poorer quality of life  
compared with female.  This difference might be due to  
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Table 2.  Distribution of Child Criteria Based on Sex 
Child Criteria Male Female 
A 10 9 
B 12 15 
C 8 11 
TOTAL 30 35 
X2=0.477; p>0.05 
Table 3.  Distribution of Nutritional Status Based on Sex 
Nutritional Status Male Female 
Good 5 26 
Poor 21 5 
Severe malnutrition 4 4 
TOTAL 30 35 
X2=23.83; p>0.05 
Table 4.  Distribution of Quality of Life Based on Sex 
Quality of Life Male Female 
Good 9 7 
Poor 14 21 
Very poor 7 7 
TOTAL 30 35 
X2=1.27; p>0.05 
 
Table 5.  Distribution of Quality of Life Based on Child Criteria 
Child Good 
Quality of 
life 
Average 
Quality of life 
Poor Quality 
of Life 
A 13 6 0 
B 2 22 3 
C 1 7 11 
TOTAL 16 35 114 
X= 44.655; p<0.05 
Table 6. Distribution of Quality of Life Based on Nutritional Status 
Nutritional Status Good 
Quality of 
Life 
Average 
Quality of 
Life 
Poor Quality of 
Life 
Good 9 20 2 
Poor 7 12 7 
Severe malnutrition 0 3 5 
TOTAL 16 35 14 
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the difference in the number of subjects, where Nose et
al had a larger number of men with cirrhosis due to
alcohol.
A.2 Age
Another study involving 620 samples demonstrated
no correlation between the quality of life, life
expectancy and the age of patients with liver cirrhosis.
This differs from this study, where age had no
correlation with the quality of life of patients with liver
cirrhosis (r=0.1107; p>0.05).  Such difference might be
due to an inadequate number of samples for
comparison. Therefore, further study with large number
of samples is necessary to determine the difference of
results.
A.3 Child Criteria
The result of the correlation analysis between the
quality of life with the Child criteria was r=0.6819, p<0.05.
The results demonstrated a strong correlation between
Child criteria and the quality of life.  Previous studies
also demonstrated the same result. Angeli et al (1998)
concluded that Child criteria demonstrated a correlation
with the quality of life of patients with liver cirrhosis.
Vogel et al (1995) reported the same results.
A.4 Nutritional Status
Nutritional status was positively correlated with the
quality of life (r=0.3715; p<0.05). Thus, it can be
concluded that the worse the nutritional status, the worse
also the quality of life.  Study that analyzed the
correlation between the nutritional status and the quality
of life by searching for the correlation between the level
of plasma albumin and the patients’ quality of life has
also been reported, demonstrating that lower levels of
albumin was also correlated with a lower quality of life.
CONCLUSION
From this study, it can be concluded that 65 study
subjects experienced a reduced quality of life.  Factors
positively correlated with the quality of life were
nutritional status and Child criteria.  Age and sex factors
did not correlate with the quality of life.
This is a preliminary study on the quality of life of
patients with liver cirrhosis.  Further study with larger
samples taking into account special aspects in the
management of patients with liver cirrhosis is required.
REFERENCES
1. Merican L. Complication of cirrhosis. In: R. Guan, J.Y., Kang
H.S. Ng (eds). Management of common gastroenterological
problems. 2nd ed. 1995.p. 166-82.
2. Adenan H, Atmojo BTP, Soeliadi HW. Keluhan utama penderita
sirosis hati di RSUP Dr. Sardjito Yogyakarta. Kumpulan Makalah
KOPAPDI VII. Jilid III. Yogyakarta.1990; 131-8.
3. Ganz PA. Quality of life and patient with cancer. Individual and
policy implications. Cancer. 1994.p.74:1445-52.
4. Younossi Z.M, Guyatt G. Quality of life assesments and chronic
liver disease. Am J Gastroenterol 1998; 93: 1037-41.
5. Sja’bani M, Siswanto A, Sunarto H, Maduseno S & Asdie AH.
Quality of life and functional status in patients with end stage
renal disease who undergo chronic hemodialysis at General
Hospital of Sardjito, Yogyakarta. Berkala Epidemiologi Klinik
& Biostatistik Indonesia Vol. 1 No. 1, 1994.
6. Spitzer WO, Dospson AJ, Hall J, Levi J, Battista RN.
Measuring the quality of life of cancer patients. A concide
QL-index for use by physicians. J Chron Disease 1981; 34:
585-97.
7. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman
RK. Changes in quality of life after liver transplantation among
adults. Liver transplantation and surgery. Vol.3 No.2. 1997; 2:
93-104.
8. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC,
Perilo RP, Assesing health related quality of life in chronic
hepatitis C using the sickness impact profile. Clin Ther 1994;
16(2): 334-43.
9. Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN,
Groll A, Kinnear D, Saibil F, McDonald JW. Quality of life: a
valid and reliable measure therapeutic efficacy in the treatment
of inflammatory bowel disease. Canadian chron’s relapse
prevential trial study group. Gastroenterology 1994; 106(2):
2878-96.
10. Inturri P, Graziotto A, Rossaro L. Treatment of ascites old and
new remedies. Dig Dis 1996; 14(3): 145-56.
11. Rabin L, Chedid A, Mendenhall CL, Gartside P, French SW,
Chen T. Prognostic factors in alcoholic liver disease. VA
Cooperative Study Group. Am J Gastroenterol 1991; 86(2):
210-6.
12. Vogel W, Propst A, Propst T, Zangerl G, Ofner D, Judmaier G.
Prognosis and life expectancy in chronic liver disease. Dig Dis
Sci 1995; Aug 40(8): 1805-15.
13. Nose Y, Sugimura T, Sakai H, Nawata H, Sakamoto M, Azakawa
K. Etiology and prognosis of liver cirrhosis in elderly patients.
Fukuoka Igaku Zasshi, Nov ed. 1995; 86(11): 411-6.
14. Angeli P, Merkel C, Morabito A, Sacerdoti D, Bolognesi M,
Gatta A. Updating prognosis of cirrhosis by Cox’s regression
model using Child-Pugh score and aminopyrine breath test as
time-dependent covariates. Am J Gastroenterol. Feb 1998; 86(2):
232-9.
15. Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P,
Tapias J, Christensen E, Giustina G, Noventa F. Survival and
prognosis factors in 366 patients with compensated cirrhosis
type B: a multicenter study. The investigators of the European
Concerted Action on Viral Hepatitis (EUROHEP). J. Hepatol
Oct 1994; 21(4): 656-66.
